# BATCH2-PROMOTE-1 — Cleared Wave Package Promotion

**Work ID:** `BATCH2-PROMOTE-1_cleared_wave_package_promotion`  
**Date:** 2026-06-06  
**SOP:** AUTOMATION_BUS_SOP_v1.3.1

---

## Executive verdict

**PASS.** All **10/10** cleared Batch 2 packages governance-promoted. **10/10** excluded packages untouched. **20/20** pre/post package validators PASS for included set. Architecture gate **PASS**. **No runtime activation** performed (`runtime_authority_status` remains `inactive`; `latest_knowledge_status.json` not updated). **No medical logic, signal, threshold, or evaluator changes.**

---

## Preflight findings

| Check | Result |
|-------|--------|
| Cleared packages found | 10/10 |
| Excluded packages out of scope | 10/10 confirmed |
| Package validators (pre) | 10/10 PASS |
| Provenance canonical | 10/10 |
| Frame indexed | 10/10 |
| Activation-key collision | None (no active duplicate keys) |
| Pre-promotion state | `compiled_not_promoted` / inactive |

---

## Promotion method

Per repo convention (promotion ≠ runtime activation):

1. **Package manifest governance metadata** — added `governance_promotion_status`, `governance_promotion_register`, `governance_promoted_work_id` to each cleared package (metadata only; no signal/research changes).
2. **Medical frame identity index** — `frame_role` → `pass3_frame_governance_promoted`; `promotion_state` remains `compiled_not_promoted`; `runtime_authority_status` remains `inactive`.
3. **Execution register** — `knowledge_bus/governance/batch2_promote_1_execution_register_v1.yaml`.

`knowledge_bus/current/latest_knowledge_status.json` was **not** updated (activation deferred).

---

## Included packages (promoted)

| package_id | panel | activation_key |
|------------|-------|----------------|
| pkg_kb47_creatine_kinase_high_exertional_muscle_injury | muscle_injury | signal_creatine_kinase_high::inv_creatine_kinase_high_exertional_muscle_injury |
| pkg_kb47_creatine_kinase_high_persistent_nonexertional_muscle_injury | muscle_injury | signal_creatine_kinase_high::inv_creatine_kinase_high_persistent_nonexertional_muscle_injury |
| pkg_kb47_eosinophil_pct_high_reactive_atopic_eosinophilia | eosinophil | signal_eosinophil_pct_high::inv_eosinophil_pct_high_reactive_atopic_eosinophilia |
| pkg_kb47_eosinophil_pct_high_secondary_or_systemic_eosinophilia | eosinophil | signal_eosinophil_pct_high::inv_eosinophil_pct_high_secondary_or_systemic_eosinophilia |
| pkg_kb47_eosinophils_abs_high_reactive_eosinophilic_inflammation | eosinophil | signal_eosinophils_abs_high::inv_eosinophils_abs_high_reactive_eosinophilic_inflammation |
| pkg_kb47_eosinophils_abs_high_hypereosinophilic_or_secondary_eosinophilia | eosinophil | signal_eosinophils_abs_high::inv_eosinophils_abs_high_hypereosinophilic_or_secondary_eosinophilia |
| pkg_kb47_free_t3_high_t3_predominant_thyrotoxicosis | thyroid | signal_free_t3_high::inv_free_t3_high_t3_predominant_thyrotoxicosis |
| pkg_kb47_free_t3_low_low_t3_syndrome | thyroid | signal_free_t3_low::inv_free_t3_low_low_t3_syndrome |
| pkg_kb47_free_t4_high_thyrotoxicosis_context | thyroid | signal_free_t4_high::inv_free_t4_high_thyrotoxicosis_context |
| pkg_kb47_free_t4_low_thyroid_hormone_deficiency | thyroid | signal_free_t4_low::inv_free_t4_low_thyroid_hormone_deficiency |

**Post-promotion state:** `governance_promoted_pending_runtime_activation`

---

## Excluded packages (unchanged)

All 8 androgen + 2 eGFR packages — no file modifications.

---

## Panel decisions

| Panel | Decision |
|-------|----------|
| Androgen (8) | Excluded — CF-BATCH2-010 clinical signoff; CF-CONTEXT-MOD-3 runtime binding |
| eGFR (2) | Excluded — CF-BATCH2-007 creatinine/eGFR adjudication |
| Thyroid (4) | **Promoted** (governance) — clinical sign-off still required before runtime activation |

---

## Files changed

- `knowledge_bus/governance/batch2_promote_1_execution_register_v1.yaml` (new)
- `knowledge_bus/governance/medical_frame_identity_index_v1.yaml` (10 frame entries)
- 10 × `knowledge_bus/packages/pkg_kb47_*/package_manifest.yaml` (governance metadata only)
- `docs/sprints/launch_core_carry_forward_register.md`
- This audit report

---

## Package validation (post-promotion)

**Method:** `python backend/scripts/validate_knowledge_package.py --package-dir <pkg>` for all 10 included packages.

**Result:** 10/10 PASS (`ready_for_implementation: True`).

---

## Architecture gate

```text
architecture_validation_gate: PASS
validation_status: PASS (frame index)
validation_status: PASS (context modifier catalogue)
medical_intelligence_architecture_validation: PASS
test_med_frame_identity_index: 11 passed
```

---

## Runtime activation status

**Not performed.** All promoted frames retain `runtime_authority_status: inactive`. SignalRegistry / SignalEvaluator / loaders unchanged.

---

## Carry-forward updates

| ID | Action |
|----|--------|
| CF-BATCH2-011 | **Resolved** — BATCH2-PROMOTE-1 executed for 10 cleared packages |
| CF-BATCH2-007 | Remains Open |
| CF-BATCH2-010 | Remains Open |
| CF-CONTEXT-MOD-3 | Remains Open |

---

## Remaining blockers

- Runtime activation wire sprint required before cleared packages become `runtime_active_canonical`
- Thyroid clinical sign-off before activation (CF-BATCH2-010 adjacency)
- Androgen and eGFR packages remain excluded

---

## Recommended next step

Controlled **runtime activation** sprint for cleared subset (separate from this governance promotion), with explicit activation-key authority switch and rollback path — analogous to KB-UTIL-2-PROMOTE-WIRE-1 pattern.

---

## Confirmations

- No excluded package files modified
- No signal_library, research_brief, or promoted_signal_intelligence content changes
- No frontend, SSOT, scoring, or evaluator changes
